WATSON 3700 (Ropinirole hydrochloride extended-release 6 mg)

Pill imprint WATSON 3700 has been identified as Ropinirole hydrochloride extended-release 6 mg.

Ropinirole is used in the treatment of parkinson's disease; restless legs syndrome; periodic limb movement disorder; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Ropinirole 6 mg is not a controlled substance under the Controlled Substance Act (CSA).

Ropinirole hydrochloride extended-release

Imprint:

WATSON 3700

Strength:

6 mg

Color:

White

Shape:

Elliptical / Oval

Availability:

Prescription only

Drug Class:

Dopaminergic antiparkinsonism agents

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Watson Laboratories, Inc.

National Drug Code (NDC):

00591-3700

Inactive Ingredients:

hypromelloses
mannitol
glyceryl dibehenate
lactose monohydrate
hydrogenated castor oil
povidone
sodium lauryl sulfate
magnesium silicate
magnesium stearate
silicon dioxide
triethyl citrate
titanium dioxide
polydextrose
triacetin
polyethylene glycol 8000
vinyl acetate

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
42291-0710	AvKare, Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.